Dominik Małek
Research Subjects
Dominik Małek has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Klaudia Sztaba
Hospital of the Order of Brothers Hospitallers of St. John Grande, Trynitarska 11, 31-061 Krakow, Poland
2 shared publications - Marta Siwek
St. Adalbert's Hospital, Copernicus PL, al. Jana Pawła II 50, 80-462 Gdańsk, Poland
2 shared publications - Paweł Jurczak
Hospital of the Order of Brothers Hospitallers of St. John Grande, Trynitarska 11, 31-061 Krakow, Poland
2 shared publications - Paweł Karol Puczel
St. Adalbert's Hospital, Copernicus PL, al. Jana Pawła II 50, 80-462 Gdańsk, Poland
2 shared publications
Latest Publications
- Open Access
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
CLINICAL UTILITY OF CYFRA 21-1 IN ONCOLOGY: A COMPREHENSIVE REVIEW OF CURRENT EVIDENCE AND FUTURE DIRECTIONS
CYFRA 21-1, a soluble fragment of cytokeratin-19 released during epithelial cell apoptosis and necrosis, has emerged as a promising serum biomarker across a wide range of epithelial malignancies. This review synthesizes current evidence regarding its diagnostic, prognostic, and predictive roles in oncology, with emphasis on its clinical applicability, limitations, and future perspectives. Elevated baseline concentrations of CYFRA 21-1 consistently correlate with greater tumor burden, advanced stage, and poorer survival in cancers such as non–small cell lung cancer, head and neck squamous carcinoma, esophageal, colorectal, breast, thyroid, and urothelial tumors. Serial measurement provides additional clinical insight, as reductions during treatment reflect therapeutic response, whereas rising levels may precede radiologic or clinical relapse. Despite these strengths, limited sensitivity in early-stage disease, biological heterogeneity, and lack of assay standardization currently restrict universal application. Integrative approaches combining CYFRA 21-1 with complementary tumor markers, inflammatory indices, or molecular assays show improved diagnostic and prognostic performance, underscoring its potential as part of multimarker algorithms rather than a stand-alone test. Ongoing efforts to harmonize assays, define reference intervals, and evaluate kinetic behavior in prospective cohorts are essential for translation into practice. Ultimately, CYFRA 21-1 represents a biologically grounded, minimally invasive biomarker capable of enhancing personalized oncology by refining risk stratification, guiding therapeutic decisions, and enabling earlier detection of relapse. Continued validation and clinical integration may establish CYFRA 21-1 as a key component in the evolving landscape of evidence-based cancer management.
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
Open AccessCLINICAL UTILITY OF CYFRA 21-1 IN ONCOLOGY: A COMPREHENSIVE REVIEW OF CURRENT EVIDENCE AND FUTURE DIRECTIONS
CYFRA 21-1, a soluble fragment of cytokeratin-19 released during epithelial cell apoptosis and necrosis, has emerged as a promising serum biomarker across a wide range of epithelial malignancies. This review synthesizes current evidence regarding its diagnostic, prognostic, and predictive roles in oncology, with emphasis on its clinical applicability, limitations, and future perspectives. Elevated baseline concentrations of CYFRA 21-1 consistently correlate with greater tumor burden, advanced stage, and poorer survival in cancers such as non–small cell lung cancer, head and neck squamous carcinoma, esophageal, colorectal, breast, thyroid, and urothelial tumors. Serial measurement provides additional clinical insight, as reductions during treatment reflect therapeutic response, whereas rising levels may precede radiologic or clinical relapse. Despite these strengths, limited sensitivity in early-stage disease, biological heterogeneity, and lack of assay standardization currently restrict universal application. Integrative approaches combining CYFRA 21-1 with complementary tumor markers, inflammatory indices, or molecular assays show improved diagnostic and prognostic performance, underscoring its potential as part of multimarker algorithms rather than a stand-alone test. Ongoing efforts to harmonize assays, define reference intervals, and evaluate kinetic behavior in prospective cohorts are essential for translation into practice. Ultimately, CYFRA 21-1 represents a biologically grounded, minimally invasive biomarker capable of enhancing personalized oncology by refining risk stratification, guiding therapeutic decisions, and enabling earlier detection of relapse. Continued validation and clinical integration may establish CYFRA 21-1 as a key component in the evolving landscape of evidence-based cancer management.
- Open Access
- 3 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 85, 66384
Optimizing Pain Management in Truncal Surgery: A Narrative Review of Regional Anesthetic Techniques
Background. Effective postoperative analgesia is essential for optimizing recovery and enhancing patient satisfaction after surgery. Regional anesthesia techniques, particularly fascial plane blocks, are key components of multimodal analgesia, offering targeted somatic and sometimes visceral pain relief.Aim. To review the indications, techniques, efficacy, contraindications, and complications of commonly used truncal regional anesthesia blocks, including TAP, subcostal TAP, quadratus lumborum, rectus sheath, ilioinguinal/iliohypogastric, intercostal, PECS I & II, and serratus anterior plane blocks.Material and methods. A narrative review of recent clinical studies and systematic reviews was performed, focusing on ultrasound-guided fascial plane blocks in abdominal, thoracic, and breast surgeries. Data on efficacy, safety, and clinical application were synthesized to guide perioperative analgesic strategies.Results. TAP and subcostal TAP blocks effectively reduce somatic pain after lower and upper abdominal surgery, respectively, while quadratus lumborum blocks provide both somatic and visceral analgesia. Rectus sheath and ilioinguinal/iliohypogastric blocks are effective for midline and lower abdominal procedures. Intercostal, PECS, and serratus anterior plane blocks offer targeted analgesia for thoracic and breast surgery. Ultrasound guidance enhances safety and efficacy. Complications are rare and include local anesthetic toxicity, bleeding, infection, or block failure, with specific risks such as pneumothorax (ICNB) or transient femoral nerve palsy (TAP, ilioinguinal/iliohypogastric).Conclusions. Truncal regional anesthesia techniques play a vital role in multimodal analgesia, improving pain control, reducing opioid use, and supporting enhanced recovery after surgery. Optimal block selection should be tailored to the surgical site and patient factors. Further high-quality studies are needed to refine techniques and optimize outcomes.
- 3 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 85, 66384
Open AccessOptimizing Pain Management in Truncal Surgery: A Narrative Review of Regional Anesthetic Techniques
Background. Effective postoperative analgesia is essential for optimizing recovery and enhancing patient satisfaction after surgery. Regional anesthesia techniques, particularly fascial plane blocks, are key components of multimodal analgesia, offering targeted somatic and sometimes visceral pain relief.Aim. To review the indications, techniques, efficacy, contraindications, and complications of commonly used truncal regional anesthesia blocks, including TAP, subcostal TAP, quadratus lumborum, rectus sheath, ilioinguinal/iliohypogastric, intercostal, PECS I & II, and serratus anterior plane blocks.Material and methods. A narrative review of recent clinical studies and systematic reviews was performed, focusing on ultrasound-guided fascial plane blocks in abdominal, thoracic, and breast surgeries. Data on efficacy, safety, and clinical application were synthesized to guide perioperative analgesic strategies.Results. TAP and subcostal TAP blocks effectively reduce somatic pain after lower and upper abdominal surgery, respectively, while quadratus lumborum blocks provide both somatic and visceral analgesia. Rectus sheath and ilioinguinal/iliohypogastric blocks are effective for midline and lower abdominal procedures. Intercostal, PECS, and serratus anterior plane blocks offer targeted analgesia for thoracic and breast surgery. Ultrasound guidance enhances safety and efficacy. Complications are rare and include local anesthetic toxicity, bleeding, infection, or block failure, with specific risks such as pneumothorax (ICNB) or transient femoral nerve palsy (TAP, ilioinguinal/iliohypogastric).Conclusions. Truncal regional anesthesia techniques play a vital role in multimodal analgesia, improving pain control, reducing opioid use, and supporting enhanced recovery after surgery. Optimal block selection should be tailored to the surgical site and patient factors. Further high-quality studies are needed to refine techniques and optimize outcomes.